Antioxidant status modifications by topical administration of dorzolamide in primary open-angle glaucoma

European Journal of Ophthalmology

Volumn 19, Issue 4, 2009, Pages 565-571

  Zanon Moreno, Vicente ^a   Garcia Medina, Jose J ^a   Gallego Pinazo, Roberto ^a   Vinuesa Silva, Ignacio ^b   Moreno Nadal, Maria A ^a   Pinazo Duran, Maria D ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b Hospital de Punta Europa   (Spain)

Author keywords

Antioxidant; Dorzolamide; Free radicals; Glaucoma; Oxidative stress

Indexed keywords

DORZOLAMIDE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; AQUEOUS HUMOR; CARBONIC ANHYDRASE INHIBITORS; CASE-CONTROL STUDIES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SULFONAMIDES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOPHENES;

EID: 70549083668     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900408     Document Type: Article

References (35)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-93.
2. Tavares IM, Mello PA. Normal tension glaucoma. Arq Bras Oftalmol 2005; 68: 565-75.
3. Chen PP. Risk and risk factors for blindness from glaucoma. Curr Opin Ophthalmol 2004; 15: 107-11.
4. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007; 2: 219-36.
5. Ottonello S, Foroni C, Carta A, Petrucco S, Maraini G. Oxidative stress and age-related cataract. Ophthalmologica 2000; 214: 78-85.
6. Caldwell RB, Bartoli M, Behzadian MA, et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 2005; 6: 511-24.
7. Maher P, Hanneken A. The molecular basis of oxidative stress-induced cell death in an immortalised retinal ganglion cell line. Invest Ophthalmol Vis Sci 2005; 46: 749-57.
8. Haleng J, Pincemail J, Defraigne JO, Charlier C, Chapelle JP. Oxidative stress. Rev Med Liege 2007; 62: 628-38.
9. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001; 54: 176-86.
10. Fuchsjager-Mayrl G, Wally B, Rainer G, et al. Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension. Br J Ophthalmol 2005; 89: 1293-7.
11. Harris A, Arend O, Arend S, Martin B. Effects of topical dorzolamide on retinal and retrobulbar hemodynamics. Acta Ophthalmol Scand 1996; 74: 569-72.
12. Kniep EM, Roehlecke C, Ozkucur N, et al. Inhibition of apoptosis and reduction of intracellular pH decrease in retinal neural cell cultures by a blocker of carbonic anhydrase. Invest Ophthalmol Vis Sci 2006; 47: 1185-92.
13. Jentzsch AM, Bachmann H, Furst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996; 20: 251-6.
14. Lefevre G, Beljean-Leymarie M, Beyerle F, et al. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Ann Biol Clin (Paris) 1998; 56: 305-19.
15. DiSilvestro RA, David C, David EA. Comparison of four indirect methods for fluid superoxide dismutase activities. Free Radic Biol Med 1990; 9: 507-10.
16. Freedman SF, Anderson PJ, Epstein DL. Superoxide dismutase and catalase of calf trabecular meshwork. Invest Ophthalmol Vis Sci 1985; 26: 1330-5.
17. McLauchlan WR, Sanderson J, Quinlan M, Williamson G. Measurement of the total antioxidant activity of human aqueous humor. Clin Chem 1998; 44: 888-9.
18. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54: 356-61.
19. Makashova NV, Babenkova IV, Teselkin IO. The antioxidant activity of the lacrimal fluid in patients with primary open-angle glaucoma. Vestn Oftalmol 1999; 115: 3-4.
20. Fatokun AA, Stone TW, Smith RA. Oxidative stress in neurodegeneration and available means of protection. Front Biosci 2008; 13: 3288-311.
21. Li G, Luna C, Liton PB, Navarro I, Epstein DL, Gonzalez P. Sustained stress response after oxidative stress in trabecular meshwork cells. Mol Vis 2007; 13: 2282-8.
22. Anton A, Andrada MT, Mujica V, Calle MA, Portela J, Mayo A. Prevalence of primary open-angle glaucoma in a Spanish population: the Segovia study. J Glaucoma 2004; 13: 371-6.
23. Kravchuk EA. Free-radical oxidation in the pathogenesis of eye diseases. Vestn Oftalmol 2004; 120: 48-51.
24. Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 2008; 14: 962-8.
25. Bhatia RP, Rai R, Rao GR. Role of malondialdehyde and superoxide dismutase in cataractogenesis. Ann Ophthalmol (Skokie) 2006; 38: 103-6.
26. Dubinina EE, Pustygina AV. Free radical processes in ageing, neurodegenerative diseases and other pathological states. Biomed Khim 2007; 53: 351-72.
27. Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 2008; 46: 499-505.
28. Michels M, Sternberg P. Jr. Operating microscope-induced retinal phototoxicity: pathophysiology, clinical manifestations and prevention. Surv Ophthalmol 1990; 34: 237-52.
29. Augustin AJ, Dick HB. Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices. J Cataract Refract Surg 2004; 30: 424-7.
30. Zanon-Moreno V, Pons S, Gallego-Pinazo R, et al. Implicaciones del óxido nítrico y otras moléculas con potencial redox en el glaucoma primario de ángulo abierto. Arch Soc Esp Oftalmol 2008; 83: 365-72.
31. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy S. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004; 137: 62-9.
32. Saccà SC, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp Eye Res 2007; 84: 389-99.
33. Yildirim O, Ate NA, Ercan B, et al. Role of oxidative stress enzymes in open-angle glaucoma. Eye 2005; 19: 580-3.
34. Detry-Morel M, De Hoste F. Treatment of glaucoma with carbonic anhydrase inhibitors in eyewash: medium term retrospective experience with dorzolamide. Bull Soc Belge Ophtalmol 1997; 267: 157-66.
35. Izzotti A, Saccà SC, Di Marco B, Penco S, Bassi AM. Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course. Eye 2008; 22: 445-53.